| NCI pathway | Validated targets of C-MYC transcriptional repression, myc_represspathway; HIF-1-alpha transcription factor network, hif1_tfpathway; Signaling mediated by p38-alpha and p38-beta, p38alphabetadownstreampathway; Nongenotropic Androgen signaling, ar_nongenomic_pathway; ErbB1 downstream signaling, erbb1_downstream_pathway; Glucocorticoid receptor regulatory network, reg_gr_pathway; Regulation of nuclear SMAD2/3 signaling, smad2_3nuclearpathway; LKB1 signaling events, lkb1_pathway; Integrin-linked kinase signaling, ilk_pathway; Trk receptor signaling mediated by the MAPK pathway, mapktrkpathway; VEGFR3 signaling in lymphatic endothelium, lymphangiogenesis_pathway; LPA4-mediated signaling events, lpa4_pathway; p38 signaling mediated by MAPKAP kinases, p38_mk2pathway; AP-1 transcription factor network, ap1_pathway; FOXA2 and FOXA3 transcription factor networks, hnf3bpathway; ATF-2 transcription factor network, atf2_pathway; Signaling events regulated by Ret tyrosine kinase, ret_pathway; Trk receptor signaling mediated by PI3K and PLC-gamma, pi3kplctrkpathway |
|---|
| WIKI pathway | DNA Damage Response(Homo sapiens), WP707; Leptin signaling pathway(Homo sapiens), WP2034; SIDS Susceptibility Pathways(Mus musculus), WP1266; SREBP signalling(Homo sapiens), WP1982; Corticotropin-releasing hormone(Homo sapiens), WP2355; TCR Signaling Pathway(Homo sapiens), WP69; Interferon type I signaling pathways(Homo sapiens), WP585; G1 to S cell cycle control(Homo sapiens), WP45; BDNF signaling pathway(Homo sapiens), WP2380; miRNA regulation of DNA Damage Response(Mus musculus), WP2087; Adipogenesis genes(Mus musculus), WP447; PluriNetWork(Mus musculus), WP1763; Serotonin Receptor 4/6/7 and NR3C Signaling(Homo sapiens), WP734; ATM Signaling Pathway(Homo sapiens), WP2516; p38 MAPK Signaling Pathway(Homo sapiens), WP400; miRNA Regulation of DNA Damage Response(Homo sapiens), WP1530; Interleukin-11 Signaling Pathway(Homo sapiens), WP2332; Oncostatin M Signaling Pathway(Homo sapiens), WP2374; Adipogenesis(Homo sapiens), WP236; EGF/EGFR Signaling Pathway(Homo sapiens), WP437; EGFR1 Signaling Pathway(Mus musculus), WP572; Estrogen signalling(Mus musculus), WP1244; IL-3 Signaling Pathway(Mus musculus), WP373; Folate-Alcohol and Cancer Pathway(Homo sapiens), WP1589; Myometrial Relaxation and Contraction Pathways(Mus musculus), WP385; Mitochondrial Gene Expression(Homo sapiens), WP391; Hypothetical Network for Drug Addiction(Mus musculus), WP1246; miRNAs involved in DNA damage response(Homo sapiens), WP1545; Integrated Breast Cancer Pathway(Homo sapiens), WP1984; Myometrial Relaxation and Contraction Pathways(Homo sapiens), WP289; FSH signaling pathway(Homo sapiens), WP2035; TSH signaling pathway(Homo sapiens), WP2032; B Cell Receptor Signaling Pathway(Homo sapiens), WP23; Androgen receptor signaling pathway(Homo sapiens), WP138; SIDS Susceptibility Pathways(Homo sapiens), WP706; Estrogen signaling pathway(Homo sapiens), WP712; Integrated Pancreatic Cancer Pathway(Homo sapiens), WP2377; Mitochondrial Gene Expression(Mus musculus), WP1263; p38 MAPK Signaling Pathway(Mus musculus), WP350; Hypothetical Network for Drug Addiction(Homo sapiens), WP666 |
|---|